Skip to content

treatment of infectious corneal ulcers resistant

Comparison of two treatments corneal collagen cross-linking(CXL) and povidone-iodine 1% solution in the treatment of infectious corneal ulcers resistant to conventional drug treatment

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221230056988N1
Enrollment
30
Registered
2023-03-14
Start date
2023-03-21
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

corneal ulcer. Corneal ulcer

Interventions

Intervention 1: Intervention group: In the first group, the continuation of the routine treatment along with cross-linking (as described in the text) by CXL device (Avedro model from Tovana Radio Equi
@3mw/cm2) which injects 4.5 J/cm2 into the cornea. The steps of the surgical protocol are as follows:1- The patient is covered with a cloth under sterile conditions and the cornea is numbed locally wi

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Every patient with infectious corneal ulcer resistant to routine treatment

Exclusion criteria

Exclusion criteria: Withdrawal from the study during the research for any reason Unwillingness to participate in the study Absence of a regular clinical record History or presence of previous eye disease Systemic diseases have been proven to be effective in the treatment process, such as diabetes, autoimmune diseases, etc. Impossibility of patient follow-up

Design outcomes

Primary

MeasureTime frame
Average size and area of the wound. Timepoint: Measurement of the average size and area of the wound before treatment, one day, three days, one week, 14 days, 21 days and 28 days after treatment. Method of measurement: slit-lamp device in two axes (the largest size and the smallest size).;Frequency of stromal infiltration in corneal ulcer. Timepoint: Frequency of stromal infiltration before treatment, one day, three days, one week, 14 days, 21 days, 28 days after treatment. Method of measurement: slit-lamp device (from +4 to +1).;Frequency of blunting of wound edges. Timepoint: Frequency of blunting of wound edges before treatment, one day, three days, one week, 14 days, 21 days, 28 days after treatment. Method of measurement: Slit-lamp device +1 to +4.;Recovery time. Timepoint: Recovery time before treatment, one day, three days, one week, 14 days, 21 days, 28 days after treatment. Method of measurement: From the patient's file.;Frequency of wound penetration. Timepoint: Frequency of wound penetration before treatment, one day, three days, one week, 14 days, 21 days, 28 days after treatment. Method of measurement: slit-lamp device (grade one: limited to the anterior 1/3 of the cornea, grade two: limited to the anterior 2/3 of the cornea, grade three: involvement of the entire thickness of the cornea).

Secondary

MeasureTime frame
Frequency of pain. Timepoint: Frequency of pain before treatment, one day, three days, one week, 14 days, 21 days, 28 days after treatment. Method of measurement: Questionnaire yes or no.;Frequency of visual acuity. Timepoint: Frequency of visual acuity before treatment, one day, three days, one week, 14 days, 21 days, 28 days after treatment. Method of measurement: With questions and pen light: non-understanding of light (NLP), understanding of light (LP), understanding of hand movements (HM), counting fingers (CF) in meters.;Vascularization frequency. Timepoint: Frequency of vascularization before treatment, one day, three days, one week, 14 days, 21 days, 28 days after treatment. Method of measurement: slit-lamp device (yes/no).;Average hypopyon size. Timepoint: Average hypopyon size before treatment, one day, three days, one week, 14 days, 21 days, 28 days after treatment. Method of measurement: slit-lamp device (mm).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoroush Jamshidian

Zahedan University of Medical Sciences

jamshidian.sory@gmail.com+98 54 3321 9915

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026